Targeted inhibition of BET proteins in HPV16-positive head and neck squamous cell carcinoma reveals heterogeneous transcriptional responses is a research paper published in Frontiers in Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21 CA267518-02
NCI NIH HHS
Grant: P50 CA278595
NCI NIH HHS
Grant: P30 CA014520
NCI NIH HHS
Grant: R21 CA267518
NIDCR NIH HHS
Grant: P50 DE026787
National Institutes of Health
Grant: 2P50CA278595-06A1
Head and Neck Cancer SPORE at the University of Wisconsin
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5R21CA267518-02
Combining BET protein inhibitors with radiation in HPV oropharyngeal cancer
Fields of Study
Keywords